Autoantibody profile in the experimental model of scleroderma induced by type V human collagen by Callado, Maria R.M, Viana, Vilma S.T, Vendramini, Margarete B.G, Leon, Elaine P, Bueno, Cleonice, Velosa, Ana P.P, Teodoro, Walcy R, Yoshinari, Natalino H

Get full text

Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2 by Shinjo, Samuel K, de Souza, Fernando H C, Borges, Isabela B P, dos Santos, Alexandre M, Miossi, Renata, Misse, Rafael G, Medeiros-Ribeiro, Ana C, Saad, Carla G S, Yuki, Emily F N, Pasoto, Sandra G, Kupa, Léonard V K, Ceneviva, Carina, Seraphim, Júlia C, Pedrosa, Tatiana N, Vendramini, Margarete B G, Silva, Clóvis A, Aikawa, Nádia E, Bonfá, Eloisa

Get full text

Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity by Teodoro, Walcy Rosolia, de Jesus Queiroz, Zelita Aparecida, Dos Santos, Lais Araujo, Catanozi, Sergio, Dos Santos Filho, Antonio, Bueno, Cleonice, Vendramini, Margarete B G, Fernezlian, Sandra de Morais, Eher, Esmeralda M, Sampaio-Barros, Percival D, Pasoto, Sandra Gofinet, Lopes, Fernanda Degobbi T Q S, Velosa, Ana Paula Pereira, Capelozzi, Vera Luiza

Get full text

Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS) by Rosa, Renata F, Ugolini-Lopes, Michelle Remião, Gandara, Ana Paula Rossi, Vendramini, Margarete B G, Campanholo, Kenia Repiso, Dutra, Livia, de Andrade, Danieli Castro Oliveira

Get full text

Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial by Zanetti, Caio B., Pedrosa, Tatiana, Kupa, Léonard de V. K., Aikawa, Nadia E., Borba, Eduardo F., Vendramini, Margarete B. G., Silva, Clovis A., Pasoto, Sandra G., Bonfa, Eloisa

Get full text

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal N... by Erton, Zeynep B, K Leaf, Rebecca, de Andrade, Danieli, Clarke, Ann E, Tektonidou, Maria G, Pengo, Vittorio, Sciascia, Savino, Ugarte, Amaia, Belmont, H. Michael, Gerosa, Maria, Fortin, Paul R, Lopez-Pedrera, Chary, Atsumi, Tatsuya, Zhang, Zhouli, Cohen, Hannah, Ramires de Jesús, Guilherme, Branch, David W, Wahl, Denis, Andreoli, Laura, Rodriguez-Almaraz, Esther, Petri, Michelle, Barilaro, Giuseppe, Zuo, Yu, Artim-Esen, Bahar, Willis, Rohan, Quintana, Rosana, Vendramini, Margarete BG, Barber, Megan W, Bertolaccini, Maria L, Roubey, Robert, Erkan, Doruk

Get full text

Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching by Brunelli, Juliana Barbosa, Silva, Clovis Almeida, Pasoto, Sandra Gofinet, Saa, Carla Gonçalves Schahin, Kozu, Katia Tomie, Goldenstein-Schainberg, Claudia, Leon, Elaine Pires, Vendramini, Margarete B. G., Fontoura, Nicole, Bonfa, Eloisa, Aikawa, Nádia Emi

Get full text

Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19 by Sales, Lucas P., Souza, Lucas V.B., Fernandes, Alan L., Murai, Igor H., Santos, Mayara D., Vendramini, Margarete B.G., Oliveira, Ricardo M., Figueiredo, Camille P., Caparbo, Valéria F., Gualano, Bruno, Pereira, Rosa M.R.

Get full text